New ankylosing spondylitis drug to be approved
4th August 2016 — A new type of treatment for ankylosing spondylitis is to be approved for NHS funding in England and Wales.
Secukinumab was only licenced in May this year. It helps reduce pain and inflammation, and improves mobility for people with the condition.
Ankylosing spondylitis is a type of arthritis that typically causes back pain.
It affects around 200,000 people in the UK and is around 3 times more common in men than it is in women.